Canal Insurance Company’s GSK GSK Stock Holding History

Canal Insurance Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200,000	Closed	-$7.75M	–	81
2025 Q1	$7.75M	Hold	200,000	–	–	1.83%	17
2024 Q4	$6.76M	Hold	200,000	–	–	1.75%	18
2024 Q3	$8.18M	Buy	200,000 +97,500	+95%	+$3.99M	1.9%	17
2024 Q2	$3.95M	Sell	102,500 -100,000	-49%	-$4.21M	1.04%	34
2024 Q1	$8.68M	Hold	202,500	–	–	2.22%	16
2023 Q4	$7.5M	Hold	202,500	–	–	2.08%	15
2023 Q3	$7.34M	Hold	202,500	–	–	2.1%	15
2023 Q2	$7.22M	Hold	202,500	–	–	2.03%	16
2023 Q1	$7.21M	Hold	202,500	–	–	1.95%	16
2022 Q4	$7.12M	Hold	202,500	–	–	1.94%	17
2022 Q3	$5.96M	Buy	202,500 +122,500	+153%	+$4.64M	1.78%	17
2022 Q2	$4.35M	Hold	80,000	–	–	1.27%	29
2022 Q1	$4.36M	Hold	80,000	–	–	1.2%	33
2021 Q4	$4.41M	Hold	80,000	–	–	1.29%	24
2021 Q3	$3.82M	Hold	80,000	–	–	1.3%	30
2021 Q2	$3.98M	Buy	+80,000	New	+$3.84M	1.4%	27

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Canal Insurance Company's GSK Position: Q2 2025 in Review

Canal Insurance Company sold out of GSK (GSK) in Q2 2025, closing a stake of 200,000 shares — an estimated $7.75M sold.

Canal Insurance Company first reported a position in GSK in Q2 2021 and held it in 16 quarters. The position peaked at $8.68M in Q1 2024. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Canal Insurance Company reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
Canal Insurance Company sold 200,000 GSK shares in Q2 2025, an estimated $7.75M.
Canal Insurance Company first reported a position in GSK in Q2 2021 and held it in 16 quarters.
Canal Insurance Company's GSK position peaked at $8.68M in Q1 2024.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Canal Insurance Company's 13F filing for Q2 2025, filed 30 Jul 2025.